Valuation: Kenvue Inc.

Market Cap 33.67B 30.07B 28.05B 25.48B 47.95B 3,261B 48.42B 337B 132B 1,657B 126B 124B 5,329B P/E 2026 *
18.5x
P/E 2027 * 16.1x
Enterprise Value 40.77B 36.41B 33.96B 30.85B 58.06B 3,949B 58.62B 408B 159B 2,007B 153B 150B 6,453B EV / Sales 2026 *
2.61x
EV / Sales 2027 * 2.52x
Free-Float
98.88%
Yield 2026 *
4.81%
Yield 2027 * 4.92%
1 day+1.17%
1 week+2.96%
Current month+0.40%
1 month-3.59%
3 months-8.09%
6 months+2.25%
Current year+2.78%
1 week 17.16
Extreme 17.1614
17.74
1 month 17.16
Extreme 17.1614
18.23
Current year 16.56
Extreme 16.555
20.13
1 year 14.02
Extreme 14.02
20.13
3 years 14.02
Extreme 14.02
25.17
5 years 14.02
Extreme 14.02
27.8
10 years 14.02
Extreme 14.02
27.8
Manager TitleAgeSince
Chief Executive Officer 56 14/07/2025
Director of Finance/CFO 48 12/05/2026
Chief Tech/Sci/R&D Officer 57 -
Director TitleAgeSince
Chairman 70 01/05/2023
Director/Board Member 66 04/05/2023
Director/Board Member 59 08/05/2023
Date Insider Type Main position Quantity % Market Cap. Importance
02/10/26 Free

General Counsel

50,503 0.0026%
02/10/26 Free

Chief Operating Officer

50,946 0.0027%
02/10/26 Free

Chief Technology Officer

33,203 0.0017%
Change 5-day change 1-year change 3-year change Capi.($)
+1.14%+2.96%+10.26%-10.77% 33.67B
+1.88%+4.62%-0.06%+5.05% 343B
-0.09%+0.62%-2.36%-3.36% 223B
+0.06%+0.49%-5.60%+4.75% 131B
+1.02%+4.22%+12.95%+27.11% 69.52B
+0.12%+1.24%+9.93% - 45.48B
-1.12%-1.84%-26.72%-26.20% 45.31B
-0.14%+4.58%-1.50%-33.54% 34.17B
+1.31%+3.60%-18.30%-17.57% 32.09B
+0.31%+0.63%+11.51%+27.96% 20.09B
Average +0.35%-0.05%-0.99%-2.95% 97.82B
Weighted average by Cap. +0.52%+0.37%-1.23%+0.85%

Financials

2026 *2027 *
Net sales 15.6B 13.93B 12.99B 11.8B 22.21B 1,510B 22.42B 156B 61.01B 768B 58.55B 57.28B 2,468B 15.97B 14.26B 13.3B 12.08B 22.74B 1,546B 22.96B 160B 62.46B 786B 59.95B 58.65B 2,527B
Net income 1.83B 1.63B 1.52B 1.38B 2.6B 177B 2.63B 18.27B 7.15B 89.92B 6.86B 6.71B 289B 2.1B 1.88B 1.75B 1.59B 2.99B 204B 3.02B 21.02B 8.22B 103B 7.89B 7.72B 333B
Net Debt 7.1B 6.34B 5.91B 5.37B 10.11B 688B 10.21B 71.01B 27.77B 349B 26.66B 26.08B 1,124B 6.53B 5.83B 5.44B 4.94B 9.3B 633B 9.39B 65.34B 25.55B 321B 24.53B 23.99B 1,034B
Projected Income Statement - Annual - Kenvue Inc.
Logo Kenvue Inc.
Kenvue Inc. is one of the world leaders in the design, manufacture and marketing of consumer healthcare products. The group offers products for health, beauty, baby care, oral care, skin care and more. Net sales break down by family of products as follows: - self care products (42,3%): for the treatment of coughs, colds, allergies, pain, indigestion, constipation, etc. (brands Zyrtec, Benadryl, Zarbee's, Frenadol, Codral, Reactine, Tylenol, Motrin, Calpol, Nicorette, Imodium, Pepcid, Microlax, Daktarin, etc.); - personal care products (30.3%): primarily oral care, baby care, women's health and wound care products (Listerine, Desitin, Carefree, Stayfree, Band-Aid, Neosporin brands, etc.); - beauty and skin care products (27.4%): hair care products, sun protection products, face and body care products, etc. (Neutrogena, Aveeno, Clean&Clear, Lubriderm, Johnsons, Neostrata, OGX, Rogaine brands, etc.). Product marketing is assured through direct sales, distributors and the Internet. Net sales are distributed geographically as follows: North America (49%), Europe-Middle East-Africa (23%), Asia-Pacific (19.3%) and Latin America (8.7%).
Employees
21,890
Date Price Change Volume
09/10/26 $17.73 +1.14% 23,074,038
07/10/26 $17.53 -0.34% 11,879,670
06/10/26 $17.59 +1.15% 10,870,720
05/10/26 $17.39 +1.10% 13,930,930
02/10/26 $17.20 -0.12% 13,996,786
Trader
Investor
Global
Quality
ESG MSCI
A
Ratings Surperformance© - Kenvue Inc.
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
17.53USD
Average target price
19.50USD
Spread / Average Target
+11.24%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Kenvue Inc.
  1. Stock Market
  2. Stocks
  3. KVUE Stock